Why Pfizer (PFE) Outpaced the Stock Market Today

06:45pm, Thursday, 11'th Sep 2025
In the most recent trading session, Pfizer (PFE) closed at $24.83, indicating a +1.04% shift from the previous trading day.

Pfizer's Comeback Accelerates

03:08pm, Thursday, 11'th Sep 2025
Pfizer achieved 10% year-over-year Q2 2025 revenue growth to $14.7 billion, driven by Abrysvo RSV vaccine and Seagen-acquired oncology assets. Management expects over $20 billion in risk-adjusted reve
In the Large-Cap Pharmaceuticals industry, Lilly, J&J, Novartis, Pfizer and Bayer are worth retaining amid macro pressure and rising innovation.
Dividend stocks have long been a favorite for investors seeking both income and long-term growth. By combining regular cash payouts with potential stock appreciation, dividend-paying companies provide
Pfizer Inc. crushed Q2 estimates with a 36% EPS beat, proving its operational turnaround is gaining momentum despite negative market sentiment and recent stock underperformance. Aggressive cost-cuttin
Who doesn't love passive income? As investors, we love dividend stocks, especially the ones that have high yields since they provide a steady source of income and improve the total return potential.
Pfizer and partner BioNTech said on Monday their updated COVID-19 vaccine showed an increased immune response in adults aged 65 and older as well as those aged 18 through 64 with at least one underlyi

Is Pfizer a Millionaire Maker?

09:30am, Sunday, 07'th Sep 2025
Pfizer (PFE 1.28%) is a fairly well-known drugmaker, with a name that even non-healthcare-oriented types would likely know. That's a testament to the company's longevity and its success as a business.
Investors love dividend stocks, especially those with high yields, because they provide a substantial income stream and offer significant total return potential.
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (Sept. 2025)
Despite pressure from HHS Secretary RFK Jr. and pessimism from retail investors, Pfizer Inc.'s COVID-19 franchise sales were $808 million in Q2 2025, up 81.2% year-on-year. In addition, its oncology a
Pfizer's strong Q2 results, high dividend yield, and bullish chart fuel optimism despite patent losses and rising competition.
Shares of Pfizer ( NYSE: PFE ) gained 4.50% over the past month after losing 6.50% the month prior.
Investors looking to create meaningful passive income streams for retirement have a number of considerations to keep in mind.

3 Things You Need to Know if You Buy Pfizer Today

06:45am, Thursday, 04'th Sep 2025
There are a number of reasons to believe that Pfizer (PFE -0.90%) is an attractive dividend stock. The lofty 6.9% dividend yield is the obvious first reason, but the healthcare giant also has a long h
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE